The economy, inflation, tariffs, the future of media, pardon politics and other big topics that made headlines this year.
Category: Regulation and Deregulation of Industry
-
Bitcoin Price Surges to a Milestone: $100,000
The price of a single Bitcoin rose to six figures for the first time, an extraordinary level for a 16-year-old cryptocurrency once dismissed as a sideshow.
-
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance
The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
-
Trump Picks Paul Atkins to Run the S.E.C.
Mr. Atkins, a pro-business conservative, would likely take a lighter regulatory approach than the current chair of the Securities and Exchange Commission.
-
E.P.A. Again Seeks Limits on a Harmful Pesticide
After a court overturned a ban, the agency has proposed restricting chlorpyrifos to 11 food crops, illustrating the limits of federal regulation.
-
North Carolina Town Sues Duke Energy Over Climate Change
Carrboro accused Duke, one the nation’s largest utility companies, of ignoring data about climate change while increasing use of fossil fuels.
-
McDonald’s E Coli Outbreak Declared Over
Federal health agencies closed their investigations into the bacterial outbreak that sickened 104 people and was linked to onions on the fast-food chain’s signature Quarter Pounders.
-
Nursing Home Industry Wants Trump to Rescind Staffing Mandate
A Biden administration rule that imposed minimum rules on nursing levels may not survive, even though many homes lack enough workers to maintain residents’ care.
-
F.T.C. Launches Antitrust Investigation Into Microsoft
Regulators are demanding information from the company on its cloud computing, artificial intelligence and cybersecurity products.
-
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
-
RFK Jr.’s Ideas on Big Pharma and Food Align With Some of Trump’s Biggest Critics
When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics.
-
Fed Minutes Show Options Are Open on Interest Rate Cuts
Minutes from a Nov. 6-7 meeting showed that Federal Reserve policymakers saw the labor market stabilizing and signs of economic strength.